0000899243-23-015764.txt : 20230616
0000899243-23-015764.hdr.sgml : 20230616
20230616161510
ACCESSION NUMBER: 0000899243-23-015764
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230614
FILED AS OF DATE: 20230616
DATE AS OF CHANGE: 20230616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cunningham Emmett
CENTRAL INDEX KEY: 0001710382
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39114
FILM NUMBER: 231021274
MAIL ADDRESS:
STREET 1: C/O RESTORATION ROBOTICS, INC.
STREET 2: 128 BAYTECH DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563577
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461454898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 LIBERTY BLVD.
STREET 2: SUITE 230
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-725-1500
MAIL ADDRESS:
STREET 1: 45 LIBERTY BLVD.
STREET 2: SUITE 230
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-14
0
0001563577
Galera Therapeutics, Inc.
GRTX
0001710382
Cunningham Emmett
C/O CLARUS VENTURES
314 MAIN ST., 15TH FLOOR
CAMBRIDGE
MA
02142
1
0
0
0
0
Stock Option (Right to Buy)
3.27
2023-06-14
4
A
0
48000
0.00
A
2033-06-13
Common Stock
48000
0
D
This option shall vest and become exercisable on the earlier of June 14, 2024 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.
The Reporting Person disclaims beneficial ownership of these securities and the inclusion of the securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or any other purpose. The Reporting Person is an employee of Blackstone Inc. or one of its affiliates ("Blackstone"). Pursuant to arrangements between the Reporting Person and Blackstone, the Reporting Person is required to transfer to Blackstone any and all compensation received in connection with his directorship for any company Blackstone invests in or advises.
Dr. Cunningham, an employee of an affiliate of Blackstone, is a member of the board of directors of the issuer. Dr. Cunningham disclaims beneficial ownership of any securities of the issuer that may be deemed to be beneficially owned by affiliates of Blackstone.
/s/ Emmett Cunningham
2023-06-16